BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28333250)

  • 21. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C; Ni W; Cai X; Cui J
    Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use.
    Lewis SA; Altemeier WA
    Chemotherapy; 1976; 22(5):319-23. PubMed ID: 947710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature.
    Lebrun-Vignes B; Kreft-Jais C; Castot A; Chosidow O;
    Br J Dermatol; 2012 Jun; 166(6):1333-41. PubMed ID: 22283782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovine pulmonary transit of tetracycline and minocycline.
    Cohen SH; Hoeprich PD; Gunther R; Merry JM; Franti CE
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):53-8. PubMed ID: 3802746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
    Dabernat H; Delmas C; Bauriaud R; Lareng MB
    Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular penetration of orally administered minocycline.
    Poirier RH; Ellison AC
    Ann Ophthalmol; 1979 Dec; 11(12):1859-61. PubMed ID: 556140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of serum protein and tissue binding of antimicrobial agents.
    Craig WA; Kunin CM
    Annu Rev Med; 1976; 27():287-300. PubMed ID: 180874
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts.
    Donahue HJ; Iijima K; Goligorsky MS; Rubin CT; Rifkin BR
    J Bone Miner Res; 1992 Nov; 7(11):1313-8. PubMed ID: 1466256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of doxycycline and minocycline.
    Saivin S; Houin G
    Clin Pharmacokinet; 1988 Dec; 15(6):355-66. PubMed ID: 3072140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for broken minocycline by NMR and HPLC techniques: a new additional resistance mechanism mediated by tetB determinant.
    Jupeau-Vessières AN; Leroux YG; Scavizzi MR; el Manouni D; Gerbaud GR
    Res Microbiol; 1989; 140(3):207-19. PubMed ID: 2694246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX.
    Volkers G; Damas JM; Palm GJ; Panjikar S; Soares CM; Hinrichs W
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1758-67. PubMed ID: 23999299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the absorption and excretion of minocycline and a comparison with doxycycline.
    Alestig K; Lindberg J
    Infection; 1974; 2(3):137-41. PubMed ID: 4415946
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacokinetics of tetracyclines and glycylcyclines].
    Vojtová V; Urbánek K
    Klin Mikrobiol Infekc Lek; 2009 Feb; 15(1):17-21. PubMed ID: 19399726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.
    Mannargudi B; McNally D; Reynolds W; Uetrecht J
    Drug Metab Dispos; 2009 Sep; 37(9):1806-18. PubMed ID: 19505990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.
    Papich MG
    Parasit Vectors; 2017 Nov; 10(Suppl 2):493. PubMed ID: 29143669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tetracyclines for the treatment of mycoplamic prostato-urethritis].
    Hofstetter A; Blenk H; Rangoonwala R
    MMW Munch Med Wochenschr; 1976 Jan; 118(2):49-50. PubMed ID: 814425
    [No Abstract]   [Full Text] [Related]  

  • 39. Minocycline.
    Jonas M; Cunha BA
    Ther Drug Monit; 1982; 4(2):137-45. PubMed ID: 7048646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses.
    Fortier LA; Motta T; Greenwald RA; Divers TJ; Mayr KG
    J Orthop Res; 2010 Apr; 28(4):522-8. PubMed ID: 19813262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.